DE60236114D1 - Zwitterkristall aus menschlicher Papillomavirus-E2-Transaktivierungsdomäne und einem Inhibitor sowie Roentgenstrukturkoordinaten, die die inhibitorbindende Tasche definieren - Google Patents
Zwitterkristall aus menschlicher Papillomavirus-E2-Transaktivierungsdomäne und einem Inhibitor sowie Roentgenstrukturkoordinaten, die die inhibitorbindende Tasche definierenInfo
- Publication number
- DE60236114D1 DE60236114D1 DE60236114T DE60236114T DE60236114D1 DE 60236114 D1 DE60236114 D1 DE 60236114D1 DE 60236114 T DE60236114 T DE 60236114T DE 60236114 T DE60236114 T DE 60236114T DE 60236114 D1 DE60236114 D1 DE 60236114D1
- Authority
- DE
- Germany
- Prior art keywords
- inhibitor
- tad
- hpv
- complex
- binding pocket
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003112 inhibitor Substances 0.000 title abstract 8
- 239000013078 crystal Substances 0.000 title abstract 2
- 101000742658 Human papillomavirus type 1 Regulatory protein E2 Proteins 0.000 title 1
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 title 1
- 239000000872 buffer Substances 0.000 abstract 2
- 239000011548 crystallization buffer Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000002156 mixing Methods 0.000 abstract 2
- 238000000746 purification Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 150000003384 small molecules Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Laminated Bodies (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30441201P | 2001-07-12 | 2001-07-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60236114D1 true DE60236114D1 (de) | 2010-06-02 |
Family
ID=23176405
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60215658T Expired - Lifetime DE60215658T2 (de) | 2001-07-12 | 2002-07-12 | Zwitterkristall aus humaner papillomavirus-e2-transaktivierungsdomäne und einem inhibitor sowie roentgen-struktur-koordinaten, die die inhibitorbindende tasche definieren |
| DE60236114T Expired - Lifetime DE60236114D1 (de) | 2001-07-12 | 2002-07-12 | Zwitterkristall aus menschlicher Papillomavirus-E2-Transaktivierungsdomäne und einem Inhibitor sowie Roentgenstrukturkoordinaten, die die inhibitorbindende Tasche definieren |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60215658T Expired - Lifetime DE60215658T2 (de) | 2001-07-12 | 2002-07-12 | Zwitterkristall aus humaner papillomavirus-e2-transaktivierungsdomäne und einem inhibitor sowie roentgen-struktur-koordinaten, die die inhibitorbindende tasche definieren |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7167801B2 (de) |
| EP (2) | EP1695980B1 (de) |
| JP (1) | JP4602665B2 (de) |
| AT (2) | ATE343588T1 (de) |
| AU (1) | AU2002317122B2 (de) |
| CA (1) | CA2448482C (de) |
| DE (2) | DE60215658T2 (de) |
| DK (2) | DK1695980T3 (de) |
| ES (2) | ES2274051T3 (de) |
| HU (1) | HUP0402069A3 (de) |
| IL (2) | IL159150A0 (de) |
| MX (1) | MXPA04000271A (de) |
| NZ (1) | NZ531068A (de) |
| WO (1) | WO2003006495A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1627323A4 (de) * | 2003-05-06 | 2008-04-09 | New Century Pharmaceuticals | Albumin-bindestellen zur bewertung von medikamentenwechselwirkungen und verfahren zur bewertung oder entwicklung von medikamenten auf der basis ihrer albumin-bindeeigenschaften |
| JP2007509605A (ja) * | 2003-05-26 | 2007-04-19 | バイオティ セラピーズ コーポレイション | 結晶性タンパク質ｖａｐ−１その用途 |
| CA2585115A1 (en) * | 2003-11-03 | 2005-05-12 | New Century Pharmaceuticals, Inc. | Albumin binding sites for evaluating drug interactions and methods of evaluating or designing drugs based on their albumin binding properties |
| US20090118301A1 (en) * | 2007-11-02 | 2009-05-07 | Arbor Vita Corporation | Compositions and Methods for Treating Cancer |
| CN112891520A (zh) * | 2021-04-13 | 2021-06-04 | 吉林省国大生物工程有限公司 | 一种预防和控制人乳头瘤病毒感染（hpv）的活性生物蛋白的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU671808B2 (en) | 1991-10-11 | 1996-09-12 | Chiron Corporation | Methods and compositions for identifying inhibitors of papilloma virus replication |
| NZ508519A (en) | 1998-05-01 | 2003-12-19 | Boehringer Ingelheim Ca Ltd | Preparation of human papillomavirus E1 having helicase activity and method therefor |
| ATE235509T1 (de) | 1998-06-30 | 2003-04-15 | Deutsches Krebsforsch | Peptide zur inhibition von hpv e7 proteinen |
| WO2000075182A1 (fr) * | 1999-06-04 | 2000-12-14 | Akira Kaji | Cristal de proteine du facteur de recyclage ribosomique (rrf) et son application sur la base de donnees de structure tridimensionnelles provenant du cristal |
| GB9921938D0 (en) | 1999-09-17 | 1999-11-17 | Univ York | Target for antiviral therapy |
| EP1232253A2 (de) * | 1999-11-16 | 2002-08-21 | Vertex Pharmaceuticals Incorporated | Caspase-7 enthaltende kristallisierbare zusammensetzungen |
| EP1345943B1 (de) | 2000-12-18 | 2007-03-21 | Boehringer Ingelheim (Canada) Ltd. | Inhibitoren des papilloma-virus |
-
2002
- 2002-07-11 US US10/193,460 patent/US7167801B2/en not_active Expired - Lifetime
- 2002-07-12 JP JP2003512265A patent/JP4602665B2/ja not_active Expired - Fee Related
- 2002-07-12 IL IL15915002A patent/IL159150A0/xx unknown
- 2002-07-12 DE DE60215658T patent/DE60215658T2/de not_active Expired - Lifetime
- 2002-07-12 EP EP06012247A patent/EP1695980B1/de not_active Expired - Lifetime
- 2002-07-12 HU HU0402069A patent/HUP0402069A3/hu unknown
- 2002-07-12 CA CA2448482A patent/CA2448482C/en not_active Expired - Fee Related
- 2002-07-12 AU AU2002317122A patent/AU2002317122B2/en not_active Ceased
- 2002-07-12 NZ NZ531068A patent/NZ531068A/en not_active IP Right Cessation
- 2002-07-12 DK DK06012247.0T patent/DK1695980T3/da active
- 2002-07-12 AT AT02745024T patent/ATE343588T1/de active
- 2002-07-12 ES ES02745024T patent/ES2274051T3/es not_active Expired - Lifetime
- 2002-07-12 DK DK02745024T patent/DK1409525T3/da active
- 2002-07-12 EP EP02745024A patent/EP1409525B1/de not_active Expired - Lifetime
- 2002-07-12 DE DE60236114T patent/DE60236114D1/de not_active Expired - Lifetime
- 2002-07-12 ES ES06012247T patent/ES2342309T3/es not_active Expired - Lifetime
- 2002-07-12 WO PCT/CA2002/001058 patent/WO2003006495A2/en active IP Right Grant
- 2002-07-12 MX MXPA04000271A patent/MXPA04000271A/es active IP Right Grant
- 2002-07-12 AT AT06012247T patent/ATE465414T1/de active
-
2003
- 2003-12-02 IL IL159150A patent/IL159150A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003006495A2 (en) | 2003-01-23 |
| CA2448482C (en) | 2011-12-06 |
| DK1695980T3 (da) | 2010-08-02 |
| ES2274051T3 (es) | 2007-05-16 |
| EP1409525B1 (de) | 2006-10-25 |
| DK1409525T3 (da) | 2007-02-05 |
| DE60215658T2 (de) | 2007-12-27 |
| IL159150A0 (en) | 2004-06-01 |
| EP1409525A2 (de) | 2004-04-21 |
| DE60215658D1 (de) | 2006-12-07 |
| NZ531068A (en) | 2006-06-30 |
| US20030082769A1 (en) | 2003-05-01 |
| ATE343588T1 (de) | 2006-11-15 |
| ES2342309T3 (es) | 2010-07-05 |
| EP1695980A2 (de) | 2006-08-30 |
| JP4602665B2 (ja) | 2010-12-22 |
| CA2448482A1 (en) | 2003-01-23 |
| HUP0402069A3 (en) | 2012-09-28 |
| WO2003006495A3 (en) | 2003-07-31 |
| AU2002317122B2 (en) | 2007-03-15 |
| IL159150A (en) | 2009-09-01 |
| ATE465414T1 (de) | 2010-05-15 |
| HUP0402069A2 (hu) | 2005-01-28 |
| EP1695980A3 (de) | 2006-09-06 |
| US7167801B2 (en) | 2007-01-23 |
| MXPA04000271A (es) | 2005-03-07 |
| JP2005512954A (ja) | 2005-05-12 |
| EP1695980B1 (de) | 2010-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0308385A (pt) | Cristais de ácido (met) acrìlico e processo para produzir e purificar ácido (met) acrìlico aquoso | |
| BRPI0410685B8 (pt) | processos de purificação do 1,3-propanodiol e composição | |
| DE60330015D1 (de) | Aza-bicycloalkylether und deren verwendung als alpha7-nachr agonisten | |
| MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
| BR9909358A (pt) | Composto, composição farmacêutica, e, processo para prevenção ou alìvio de complicações crÈnicas decorrentes de diabetes melito | |
| TW200604204A (en) | High-purity trimethylaluminum and method for purifying trimethylaluminum | |
| HRP20050641A2 (en) | New carboxylic acids and the esters thereof, pharmaceutical compositions containing these compounds and processes for the preparation thereof | |
| ATE381963T1 (de) | Verfahren zur herstellung von gereinigten partikeln | |
| TR200101424T2 (tr) | Amorf ve/veya meta-kararlı kristal bölgesi kristal hale dönüştürülmüş parçacıklar üretmek için işlem. | |
| ATE206122T1 (de) | Verbindungen, die als antiproliferative mittel und als garft inhibitoren verwendbar sind | |
| ATE554086T1 (de) | Scopin-salze und deren verwendung in verfahren zur herstellung von n-demethyl-tiotropium und tiotropiumbromid | |
| CY1106721T1 (el) | Μεθοδος παρασκευης υψηλης καθαροτητας περινδοπριλης και ενδιαμεσα χρησιμα στη συνθεση | |
| MXPA04008152A (es) | Compuestos azabiciclicos para el tratamiento de enfermedades. | |
| ATE255124T1 (de) | Verfahren zur gewinnung von phytosterinen durch kristallisation aus verminderten mengen methanols | |
| ATE353908T1 (de) | Entzündungshemmende bzw. antiallergische androstankomplexe | |
| DE60236114D1 (de) | Zwitterkristall aus menschlicher Papillomavirus-E2-Transaktivierungsdomäne und einem Inhibitor sowie Roentgenstrukturkoordinaten, die die inhibitorbindende Tasche definieren | |
| EA200501593A1 (ru) | Азабициклические производные в качестве антагонистов мускаринового рецептора | |
| ATE316086T1 (de) | Clathrat von azithromycin-hydrat mit 1,2- propylenglykol, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zusammensetzung | |
| DE60316791D1 (de) | Verfahren zur aufreinigung von lanzoprazol | |
| EA200601641A1 (ru) | Кристаллическая композиция, содержащая оксалат эсциталопрама | |
| RU94000064A (ru) | Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции | |
| DE60005304D1 (de) | Methode zur reinigung und abtrennung von (2s,3s)- oder (2r,3s)-halohydrinderivaten | |
| DE60312953D1 (de) | Stabiles lansoprazol, enthaltend mehr als 500 ppm bis zu 3000 ppm wasser und mehr als 200 ppm bis zu 5000 ppm alkohol | |
| NZ516235A (en) | Method for purification of proteins | |
| ATE540974T1 (de) | Reinigung des rekombinanten menschlichen faktors xiii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |